ALLAKOS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.05 USD | -4.55% |
|
0.00% | -61.54% |
| 03-15 | North American Morning Briefing : Inflation Worries Continue to Weigh on Mood | DJ |
| 03-14 | Allakos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Allakos Inc.
355e58b3982661bfecad8097.lzd7Hipf2Tf8gVPJ9JYX03SGle8SftK-SbuTcvlmDjs.8FhLbnkQsnad6AzxkfVE6z7TwZxACeTEOuLaIJoQRErTQg0qTRqVAL6wJA~53dc3c302b10a4946233d3e9e7c3bf35
Upcoming events on Allakos Inc.
Past events on Allakos Inc.
| 14/03/2024 20:02 | Q4 2023 Earnings Release |
| 22/02/2024 | American Academy of Allergy, Asthma & Immunology Meeting - Abstract No: 191 |
| 16/01/2024 13:00 | Phase 2 Lirentelimab Trial Results Call |
| 13/11/2023 21:02 | Q3 2023 Earnings Release |
| 09/08/2023 21:02 | Q2 2023 Earnings Release |
| 10/06/2023 07:30 | European Academy of Allergy and Clinical Immunology Hybrid Congres - Abstract No: 000406 |
| 24/05/2023 | Annual General Meeting |
| 09/05/2023 21:02 | Q1 2023 Earnings Release |
| 06/03/2023 21:02 | Q4 2022 Earnings Release |
| 10/11/2022 | Society for Immunotherapy of Cancer Meeting - Abstract ID: 1396 |
| 07/11/2022 21:05 | Q3 2022 Earnings Release |
| 04/08/2022 21:04 | Interim 2022 Earnings Release |
| 25/05/2022 22:30 | Annual General Meeting |
| 06/05/2022 21:05 | Q1 2022 Earnings Release |
| 01/03/2022 21:05 | FY 2021 Earnings Release |
| 15/02/2022 13:15 | Investor Day |
| 08/11/2021 21:05 | Q3 2021 Earnings Release |
| 26/10/2021 21:00 | American College of Gastroenterology Scientific Meeting - Poster No : P3085/S1453 |
| 25/10/2021 21:00 | American College of Gastroenterology Scientific Meeting - Poster No : P2033/S1431 |
| 25/10/2021 21:00 | American College of Gastroenterology Scientific Meeting - Poster No : P2033/S1421 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -89,9 -87,1 -3.19% | -156 -156 0.44% | -269 -238 -13.29% | -315 -309 -2.09% | 0,00 -150 - | -118 |
|
EBIT Million USD | Released Forecast Spread | -91,4 -89,1 -2.57% | -157 -140 -12.48% | -271 -249 -8.89% | -322 -317 -1.63% | -196 -173 -13.43% | -111 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -270 -246 -9.72% | -320 -319 -0.4% | -186 -167 -11.28% | -93,7 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -153 -154 0.37% | -270 -250 -8.01% | -320 -319 -0.43% | -186 -167 -10.88% | -106 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -3,10 -3,10 0% | -5,01 -4,61 -8.73% | -5,06 -5,15 1.75% | -2,14 -1,94 -10.55% | -1,19 |
| Announcement Date | 25/02/20 | 01/03/21 | 01/03/22 | 06/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -94,9 -63,6 -49.21% | -194 -16,0 -1109.55% | -47,0 -27,0 -74.2% | -30,1 -31,0 2.84% | -44,7 -37,3 -19.84% | |||||||||
|
EBIT Million USD | Released Forecast Spread | -96,1 -76,6 -25.46% | -196 -91,1 -114.68% | -49,1 -41,4 -18.69% | -31,4 -42,0 25.05% | -46,2 -42,7 -8.33% | -45,0 -43,0 -4.71% | -37,8 -42,9 11.88% | -48,2 -40,1 -20.34% | -65,0 -41,8 -55.6% | -60,2 | -31,6 | -20,6 | -37,1 | -16,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -94,4 -72,7 -29.87% | -197 -115 -71.97% | -49,1 -38,3 -28.05% | -30,8 -40,1 23.17% | -43,0 -44,8 3.98% | -42,4 -44,1 3.78% | -35,1 -45,2 22.26% | -45,6 -39,9 -14.41% | -62,6 -43,7 -43.11% | -35,5 | -25,3 | -19,5 | -19,0 | -16,6 |
|
Net income Million USD | Released Forecast Spread | -94,4 -76,7 -22.99% | -197 -106 -86.3% | -49,1 -40,2 -22.22% | -30,8 -56,8 45.69% | -43,0 -64,2 33.02% | -42,4 -41,5 -2.2% | -35,1 -42,1 16.63% | -45,6 -39,7 -14.85% | -62,6 -44,4 -41.01% | -57,4 | -29,9 | -19,3 | -36,0 | -16,6 |
|
EPS USD | Released Forecast Spread | -1,73 -1,33 -29.64% | -3,60 -1,82 -97.8% | -0,90 -0,79 -14.55% | -0,53 -0,76 29.92% | -0,50 -0,53 4.89% | -0,49 -0,49 -0.68% | -0,41 -0,50 17.17% | -0,52 -0,46 -13.75% | -0,71 -0,51 -38.05% | -0,44 | -0,34 | -0,21 | -0,20 | -0,21 |
| Announcement Date | 01/03/22 | 06/05/22 | 04/08/22 | 07/11/22 | 06/03/23 | 09/05/23 | 09/08/23 | 13/11/23 | 14/03/24 | - | - | - | - | - |
More events
Past sector events for Allakos Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALLK Stock
- Calendar Allakos Inc.
